• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE Back to Search Results
Model Number 2115
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Hypovolemia (2243); Retroperitoneal Hemorrhage (4483)
Event Date 02/20/2023
Event Type  Injury  
Manufacturer Narrative
Qn#(b)(4).An investigation has been opened to review historical data and risk documentation.A follow up report will be submitted after investigation.
 
Event Description
It was reported that: the physicians deployed an 18fr manta device over a j wire.Patient had unstable blood pressure post deployment and a retroperitoneal bleed was discovered.Additional information on 10mar2023: during a tavr procedure on 20feb the cardiac tech stated that they realized the patient had a rp bleed post procedure when patient became hypotensive.Acute cardiac life support (i.E., cpr, emergency ivp medications like epinephrine, lidocaine, etc) was performed.The tech stated that 6 units of blood were given.Cpr was initiated.The patient is reported as critical post procedure.Additional information has been requested from the account.A follow up report will be submitted after receipt of this information.
 
Manufacturer Narrative
(b)(4).The device was not returned for investigation.No return product evaluation could be completed.The device lot number was not reported for this investigation.Based on the information submitted, following an tavr procedure, a 18f manta was deployed for closure.Post-deployment the patient's blood pressure was unstable, became hypotensive, and a retroperitoneal bleed was discovered.Cpr was initiated, advanced cardiovascular life support performed, and the patient received six units of packed blood cells.Due to no information regarding the initial and deployment procedures, patient conditions and environment, no device or angiograms submitted for investigative purposes, a root cause of the retroperitoneal bleed remains undeterminable.This physician has not completed manta training and it is unknown how many manta cases this physician has performed.No manta representative and no manta trained healthcare professional were mentioned being present for this procedure.The ifu posts caution: federal law restricts this device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in interventional catheterization procedures and who has been trained in manta device use by an authorized representative of essential medical.Precautions the manta device should only be used by a licensed physician or healthcare provider trained in the use of this device.Potential adverse events as listed in the ifu, related to the deployment of vascular closure devices include retroperitoneal bleeding, and its consequences, because of failed closure in the setting of an access above the inguinal ligament or the most inferior border of the epigastric artery (iea).
 
Event Description
It was reported that: the physicians deployed an 18fr manta device over a j wire.Patient had unstable blood pressure post deployment and a retroperitoneal bleed was discovered.Additional information on 10mar2023: during a tavr procedure on (b)(6) the cardiac tech stated that they realized the patient had a rp bleed post procedure when patient became hypotensive.Acute cardiac life support (i.E., cpr, emergency ivp medications like epinephrine, lidocaine, etc) was performed.The tech stated that 6 units of blood were given.Cpr was initiated.The patient is reported as critical post procedure.Additional information has been requested from the account.A follow up report will be submitted after receipt of this information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 18F
Type of Device
VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
elaine cully
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key16536543
MDR Text Key311213822
Report Number3010252479-2023-00047
Device Sequence Number1
Product Code MGB
UDI-Device Identifier00856279007062
UDI-Public00856279007062
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number2115
Device Catalogue Number2115
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient SexFemale
Patient Weight100 KG
-
-